Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Stefano Severi; Ilaria Grassi; Alberto Bongiovanni; Silvia Nicolini; Irene Marini; Donatella Arpa; Nicoletta Ranallo; Irene Azzali; Valentina Di Iorio; Anna Sarnelli; Monti Manuela; Elena Amadori; Lucia Fabbri; Daniela Bartolini; Luigino Tosatto; Francesco Di Meco; Lorena Gurrieri; Nada Riva; Luana Calabro; Federica Matteucci; Giovanni Paganelli; Maddalena Sansovini

doi:10.2967/jnumed.123.266956

Research ArticleClinical Investigation

Open Access

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Silvia Nicolini, Irene Marini, Donatella Arpa, Nicoletta Ranallo, Irene Azzali, Valentina Di Iorio, Anna Sarnelli, Monti Manuela, Elena Amadori, Lucia Fabbri, Daniela Bartolini, Luigino Tosatto, Francesco Di Meco, Lorena Gurrieri, Nada Riva, Luana Calabro, Federica Matteucci, Giovanni Paganelli and Maddalena Sansovini

Journal of Nuclear Medicine September 2024, 65 (9) 1409-1415; DOI: https://doi.org/10.2967/jnumed.123.266956

Stefano Severi

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ilaria Grassi

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alberto Bongiovanni

2Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Silvia Nicolini

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irene Marini

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Donatella Arpa

3Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Emilia Romagna, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicoletta Ranallo

2Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irene Azzali

4Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Valentina Di Iorio

5Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Emilia Romagna, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Sarnelli

6Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Monti Manuela

4Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elena Amadori

7Radiology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lucia Fabbri

3Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Emilia Romagna, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela Bartolini

8Pathology Unit, “Maurizio Bufalini” Hospital, Cesena, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Luigino Tosatto

9Department of Neurosciences, Neurosurgery Division “M Bufalini” Hospital, Cesena, Emilia Romagna, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francesco Di Meco

10Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy;

11Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lorena Gurrieri

2Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nada Riva

2Osteoncology and Rare Tumor Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Luana Calabro

12Department of Oncology, University Hospital of Ferrara, Cona, Italy; and

13Department of Translational Medicine, University of Ferrara, Ferrara, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Federica Matteucci

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giovanni Paganelli

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maddalena Sansovini

1Nuclear Medicine and Radiometabolic Units, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 9

September 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Journal of Nuclear Medicine Sep 2024, 65 (9) 1409-1415; DOI: 10.2967/jnumed.123.266956

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Journal of Nuclear Medicine Sep 2024, 65 (9) 1409-1415; DOI: 10.2967/jnumed.123.266956

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

oncology
peptide receptor radionuclide therapy
177Lu
meningiomas

Main menu

User menu

Search

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords